Review Article

Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens : a review : review article

T.P.M. Schetters, K. Moubri, B.M. Cooke
Journal of the South African Veterinary Association | Vol 80, No 2 | a174 | DOI: https://doi.org/10.4102/jsava.v80i2.174 | © 2009 T.P.M. Schetters, K. Moubri, B.M. Cooke | This work is licensed under CC Attribution 4.0
Submitted: 22 May 2009 | Published: 22 May 2009

About the author(s)

T.P.M. Schetters,
K. Moubri,
B.M. Cooke,

Full Text:

PDF (445KB)

Abstract

abesia canis and B. rossi are large Babesia species that infect dogs and cause clinical disease. The spectrum of disease is highly diverse with either parasite, but upon evaluation of field cases it has been suggested that in general B. rossi is more virulent than B. canis. This difference was also found in experimental infections using B. canis and B. rossi isolates and appeared to be related to a difference in parasitaemia. Whether this difference reflects the essential difference between B. canis and B. rossi species in general, or merely reflects the variability in virulence of individual isolates cannot be discerned. Comparative in vitro and in vivo studies revealed a number of qualitative differences between the B. canis and B. rossi isolates studied; however, more research is required to determine any causal relationship between in vitro and in vivo characteristics. Vaccination with a bivalent vaccine (containing soluble parasite antigen [SPA] from supernatants of in vitro cultures of B. canis and B. rossi) induced protection against clinical babesiosis upon challenge infection with either parasite. The dynamics of parasitaemia upon challenge infection of vaccinated animals indicated a biological difference between the B. canis and B. rossi isolates studied. Vaccinated dogs that were challenged with B. rossi parasites (2 isolates tested) effectively controlled parasitaemia. By contrast, in vaccinated dogs that were challenged with B. canis isolates (2 isolates tested) there was little or no effect on parasitaemia but levels of SPA in plasma were reduced. Apparently the nature of vaccine-induced immunity differs with respect to the challenge species.

Keywords

Babesia canis; Babesia rossi; immunity; pathogenesis; vaccine

Metrics

Total abstract views: 4413
Total article views: 3747

 

Crossref Citations

1. A review of canine babesiosis: the European perspective
Laia Solano-Gallego, Ángel Sainz, Xavier Roura, Agustín Estrada-Peña, Guadalupe Miró
Parasites & Vectors  vol: 9  issue: 1  year: 2016  
doi: 10.1186/s13071-016-1596-0

2. Approaches for the vaccination and treatment ofNeospora caninuminfections in mice and ruminant models
ANDREW HEMPHILL, ADRIANA AGUADO-MARTÍNEZ, JOACHIM MÜLLER
Parasitology  vol: 143  issue: 3  first page: 245  year: 2016  
doi: 10.1017/S0031182015001596

3. In search of the vector(s) of Babesia rossi in Nigeria: molecular detection of B. rossi DNA in Rhipicephalus sanguineus sensu lato (Acari: Ixodidae) ticks collected from dogs, circumstantial evidence worth exploring
Joshua Kamani, Ping-Jun Chung, Chung-Chan Lee, Yang-Tsung Chung
Experimental and Applied Acarology  vol: 76  issue: 2  first page: 243  year: 2018  
doi: 10.1007/s10493-018-0311-6

4. The Diverse Pathogenicity of Various Babesia Parasite Species That Infect Dogs
Andrew L. Leisewitz, Vladimir Mrljak, Jonathan D. Dear, Adam Birkenheuer
Pathogens  vol: 12  issue: 12  first page: 1437  year: 2023  
doi: 10.3390/pathogens12121437

5. Relation of antioxidant status at admission and disease severity and outcome in dogs naturally infected with Babesia canis canis
Martina Crnogaj, José Joaquin Cerón, Iva Šmit, Ivana Kiš, Jelena Gotić, Mirna Brkljačić, Vesna Matijatko, Camila Peres Rubio, Nada Kučer, Vladimir Mrljak
BMC Veterinary Research  vol: 13  issue: 1  year: 2017  
doi: 10.1186/s12917-017-1020-9

6. Babesiosis in dogs and cats—Expanding parasitological and clinical spectra
Laia Solano-Gallego, Gad Baneth
Veterinary Parasitology  vol: 181  issue: 1  first page: 48  year: 2011  
doi: 10.1016/j.vetpar.2011.04.023

7. Pursuing effective vaccines against cattle diseases caused by apicomplexan protozoa
Monica Florin-Christensen, Leonhard Schnittger, Reginaldo G. Bastos, Vignesh A. Rathinasamy, Brian M. Cooke, Heba F. Alzan, Carlos E. Suarez
CABI Reviews  year: 2021  
doi: 10.1079/PAVSNNR202116024

8. A live vaccine against Neospora caninum abortions in cattle
Michael P. Reichel, Dadín P. Moore, Andrew Hemphill, Luis M. Ortega-Mora, J.P. Dubey, John T. Ellis
Vaccine  vol: 33  issue: 11  first page: 1299  year: 2015  
doi: 10.1016/j.vaccine.2015.01.064

9. Kanine Babesiose – Teil 2: Co-Infektionen, Therapie, Management und Prävention
Catharina Cynthia Euler
kleintier konkret  vol: 25  issue: 05  first page: 35  year: 2022  
doi: 10.1055/a-1809-0790

10. Quantitative Changes in Selected Lymphocyte Subpopulations after Administration of a Soluble Parasitic Antigen of Babesia Canis to Dogs
Łukasz Adaszek, Urszula Lisiecka, Alfonso Carbonero Martinez, Maciej Skrzypczak, Stanisław Winiarczyk
Bulletin of the Veterinary Institute in Pulawy  vol: 57  issue: 1  first page: 35  year: 2013  
doi: 10.2478/bvip-2013-0007

11. Vaccines against neosporosis: What can we learn from the past studies?
Thierry Monney, Andrew Hemphill
Experimental Parasitology  vol: 140  first page: 52  year: 2014  
doi: 10.1016/j.exppara.2014.02.015

12. Animal models of the immunology and pathogenesis of human babesiosis
Abhinav Kumar, Aditya Kabra, Ikuo Igarashi, Peter J. Krause
Trends in Parasitology  vol: 39  issue: 1  first page: 38  year: 2023  
doi: 10.1016/j.pt.2022.11.003

13. Safety and immunogenicity of a soluble native Neospora caninum tachyzoite-extract vaccine formulated with a soy lecithin/β-glucan adjuvant in pregnant cattle
Florencia Celeste Mansilla, Dadín Prando Moore, María Eugenia Quintana, Nancy Cardoso, Yanina Paola Hecker, Ignacio Gual, Wenzel Czepluch, Anselmo Carlos Odeón, Alejandra Victoria Capozzo
Veterinary Immunology and Immunopathology  vol: 165  issue: 1-2  first page: 75  year: 2015  
doi: 10.1016/j.vetimm.2015.03.007

14. Human babesiosis
Peter J. Krause
International Journal for Parasitology  vol: 49  issue: 2  first page: 165  year: 2019  
doi: 10.1016/j.ijpara.2018.11.007

15. Mechanisms Involved in the Persistence of Babesia canis Infection in Dogs
Theo Schetters
Pathogens  vol: 8  issue: 3  first page: 94  year: 2019  
doi: 10.3390/pathogens8030094

16. Kinetics of the inflammatory response during experimental Babesia rossi infection of beagle dogs
B.K. Atkinson, P. Thompson, E. Van Zyl, A. Goddard, Y. Rautenbach, J.P. Schoeman, V. Mukorera, A. Leisewitz
Veterinary Parasitology  vol: 306  first page: 109717  year: 2022  
doi: 10.1016/j.vetpar.2022.109717

17. Canine Babesiosis: Where Do We Stand?
Bilić Petra, Kuleš Josipa, Barić Rafaj Renata, Mrljak Vladimir
Acta Veterinaria  vol: 68  issue: 2  first page: 127  year: 2018  
doi: 10.2478/acve-2018-0011

18. Structural and Functional Characterization of Bc28.1, Major Erythrocyte-binding Protein from Babesia canis Merozoite Surface
Yin-Shan Yang, Brice Murciano, Karina Moubri, Prisca Cibrelus, Theo Schetters, André Gorenflot, Stéphane Delbecq, Christian Roumestand
Journal of Biological Chemistry  vol: 287  issue: 12  first page: 9495  year: 2012  
doi: 10.1074/jbc.M111.260745

19. Antioxidant status, and blood zinc and copper concentrations in dogs with uncomplicated babesiosis due to Babesia canis infections
Oliwier Teodorowski, Stanisław Winiarczyk, Duygu Tarhan, Banu Dokuzeylül, Alev Meltem Ercan, Mehmet Erman Or, Marta Staniec, Łukasz Adaszek
Journal of Veterinary Research  vol: 65  issue: 2  first page: 169  year: 2021  
doi: 10.2478/jvetres-2021-0031

20. A vaccine for human babesiosis: prospects and feasibility
Hanan Al-Nazal, Leanne M. Low, Sanjai Kumar, Michael F. Good, Danielle I. Stanisic
Trends in Parasitology  vol: 38  issue: 10  first page: 904  year: 2022  
doi: 10.1016/j.pt.2022.07.005